Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 199.2% in September

Aethlon Medical, Inc. (NASDAQ:AEMD) was the recipient of a large increase in short interest in the month of September. As of September 30th, there was short interest totalling 544,800 shares, an increase of 199.2% from the September 15th total of 182,100 shares. Based on an average daily volume of 1,800,000 shares, the short-interest ratio is presently 0.3 days.

Aethlon Medical Stock Performance

Shares of Aethlon Medical stock opened at $0.39 on Friday. The company’s 50 day moving average price is $0.40 and its 200-day moving average price is $0.70. Aethlon Medical has a 52-week low of $0.24 and a 52-week high of $2.35. The stock has a market capitalization of $5.35 million, a price-to-earnings ratio of -0.08 and a beta of 1.74.

Aethlon Medical (NASDAQ:AEMD) last issued its quarterly earnings data on Wednesday, August 14th. The medical equipment provider reported ($0.34) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.44) by $0.10. During the same quarter in the previous year, the company earned ($1.30) EPS. As a group, equities research analysts forecast that Aethlon Medical will post -1.1 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently weighed in on AEMD. StockNews.com assumed coverage on shares of Aethlon Medical in a report on Monday. They issued a “sell” rating on the stock. HC Wainwright reduced their target price on shares of Aethlon Medical from $10.00 to $7.00 and set a “buy” rating on the stock in a report on Monday, June 24th.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.